Targeting IL-34 in inflammatory autoimmune diseases

J Cell Physiol. 2019 Dec;234(12):21810-21816. doi: 10.1002/jcp.28946. Epub 2019 Jun 7.

Abstract

Interleukin-34 (IL-34) shares a common receptor with macrophage colony-stimulating factor (M-CSF), and can bind to CSF-1R, induces lymphocytes differentiation, proliferation, and regulates the synthesis of inflammatory components. Recent findings reported aberrant expression of IL-34 in several autoimmune disorders, such as lupus, arthritis, systemic sclerosis, inflammatory bowel diseases. The functional analysis further demonstrated that IL-34 may perform significantly in these inflammatory autoimmune disorders. IL-34 might consider as a biomarker for these diseases. I hope this collection of the findings in this review will improve knowledge of the role of IL-34, and targeting IL-34 may give the potential for these autoimmune diseases.

Keywords: IL-34; autoimmune; cytokine; immune cell.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology*
  • Biomarkers / analysis
  • Humans
  • Interleukins / immunology
  • Interleukins / metabolism*
  • Macrophage Colony-Stimulating Factor / immunology
  • Macrophage Colony-Stimulating Factor / metabolism*

Substances

  • Biomarkers
  • CSF1 protein, human
  • IL34 protein, human
  • Interleukins
  • Macrophage Colony-Stimulating Factor